MTOR and esophageal squamous cell carcinoma: According to Zhu et al. (2020), Omipalisib suppressed AKT activation, and downstream targets of mTOR significantly inhibited proliferation by inducing arrest of G0/G1 and activated the apoptosis process in esophageal squamous cell carcinoma (ESCC).